paricalcitol

Known as: 19-nor-1alpha,25-dihydroxyvitamin D2, paricalcitol [Chemical/Ingredient], (7e,22e)-19-Nor-9,10-Secoergosta-5,7,22-Triene-1Alpha,3Beta,25-Triol 
A synthetic noncalcemic, nonphosphatemic vitamin D analogue. Paricalcitol binds to the vitamin D receptor and has been shown to reduce parathyroid… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
020406019932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Recent studies implicate Wnt/β-catenin signaling in podocyte dysfunction. Because vitamin D analogs can inhibit β-catenin in… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Despite treatment with renin–angiotensin–aldosterone system (RAAS) inhibitors, patients with diabetes have increased… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Vitamin D receptor activation is associated with improved survival in patients with chronic kidney disease, but the mechanism of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The renal renin-angiotensin system plays a major role in determining the rate of chronic renal disease progression. Treatment… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Deficiency in vitamin D and its active metabolites is a pathologic feature of chronic kidney diseases. Despite that tubular… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Although renal osteodystrophy and vitamin D analogs may be related to survival in maintenance hemodialysis (MHD) patients, most… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The safety and efficacy of paricalcitol injection have been well established for the prevention and treatment of… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Proteinuria is a marker of cardiovascular and renal disease in patients with chronic kidney disease (CKD), and… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Elevated calcium and phosphorus levels after therapy with injectable vitamin D for secondary hyperparathyroidism may… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Management of secondary hyperparathyroidism has included the use of active vitamin D or vitamin D analogs for the… (More)
Is this relevant?